Latest News
Navicure, a provider of cloud-based claims management and patient payment solutions for physician practices and hospitals, has secured a strategic investment from Bain Capital Private Equity. Financial terms of the private transaction have not been disclosed.
Navicure, which is headquartered in Duluth, Georgia, will continue to be led by current CEO and founder, James M. Denny, Jr. and his executive team. They will retain a meaningful interest in the business. Selling shareholders include JMI Equity and other minority investors.
Navicure’s subscription-based software solutions help healthcare organisations of all sizes increase revenue, accelerate cash flow, and reduce the costs associated with
Didier Patry has been appointed Chief Executive Officer of France Brevets. He reports to the Board of Directors chaired by Philippe Caïla.
Patry succeeds Jean-Charles Hourcade who has decided to pursue other career interests. Jean-Charles Hourcade will provide him with full support in this transition period and will continue to support some of France Brevets’ strategic initiatives.
“I would like to thank Jean-Charles Hourcade for his professionalism and commitment over these last five years. France Brevets is today a major player in the monetisation of intellectual property and patent portfolios of European companies. Patents must remain more than ever in
YFM Equity Partners has launched its new YFM Equity Partners 2016 Fund (YFMEP 2016), which will provide investors with the opportunity to participate in YFM’s future private equity investments which no longer qualify for VCT investment.
YFM has already secured GBP22 million from existing pension funds and new family office backers in the last three months and following this early success are now focussing on the next stage of fundraising. The team is looking to raise an additional GBP10-15m of private equity capital to be invested over YFMEP 2016’s two-year investment period. YFMEP 2016 complements YFM’s established VCT funds, increasing
Private equity firm Warburg Pincus has appointed Stefan Krause as a Senior Advisor. He will support the firm in the identification and evaluation of new investments in Europe.
Krause has over twenty years of experience as a senior executive leading international businesses headquartered in Germany. Most recently he served as Chief Financial Officer and Member of Management Board of Deutsche Bank, Germany’s largest bank. Prior to his time at Deutsche Bank, Mr. Krause served in several management positions at Bayerische Motoren Werke Aktiengesellschaft (also known as BMW Group) in Germany and the United States, including as Chief Financial Officer.
René
Tikehau IM has acted as sole lead arranger of a EUR35 million unitranche denominated in USD for the acquisition of Cisbio Bioassays by Abénex.
Abénex acquires Cisbio Bioassays in a secondary LBO from Argos Soditic. Flexible unitranche financing denominated in US$ has been arranged by Tikehau IM.
Cisbio Bioassays is a French life sciences company committed to improving human healthcare. With more than 30 years of experience in in vitro diagnostics and drug discovery, Cisbio Bioassays provides creative technological solutions by partnering with the global scientific community in Codolet (France). Its portfolio of over 460 proprietary assays and reagents is
The Russian Direct Investment Fund (RDIF) is investing in a complex reconstruction of the federal M-4 Don highway in Russia, as part of its infrastructure partnership with Avtodor State Company.
The project involves complex installation work, reconstruction, maintenance, repair, structural repair and toll operation of the M-4 Don federal highway from Moscow through Voronezh, Rostov-on-Don, Krasnodar to Novorossiysk, at Section 4, Rostov – Krasnodar (section km 1091.6 – km 1319).
The company Road Investment Company LLC, created by RDIF and Avtodor to identify and implement road improvement projects in Russia, will act as the project operator. A number of
Dating app Once has secured a second wave of investment from Partech, the French venture capital firm, that supports global companies that they believe possess revolutionary concepts.
For this reason, Partech Ventures has just signed a second partnership deal with Once to invest a further one million euros in the dating app – signifying its confidence in the app’s successive business model.
The dating scene has become vastly populated in recent years and has been a challenging market for a new app to succeed in. Once attributes its strong continued growth in user sign ups to the fact that
Leading mid-market private equity house LDC has strengthened its support for management teams with the appointment of Chris Coulton as Portfolio Director.
Coulton joins LDC after 15 years at Deloitte where he specialised in advising mid-market private equity-backed businesses. In his new role, Coulton will work alongside LDC’s portfolio to deliver strategic and operational support that will help drive value and market-leading performance.
Coulton’s experience to date spans a range of sectors including manufacturing, energy, retail & consumer and support services. He has also previously advised LDC on several of its portfolio businesses during his time at Deloitte.
Allecra Therapeutics, a biopharmaceutical company dedicated to the development of novel antibiotics to combat drug-resistant bacterial infections, has closed a EUR22 million Series B investment round.
The round was led by new investor, Delos Capital. Existing investors Forbion Capital Partners, Edmond de Rothschild Investment Partners, EMBL Ventures and Allecra's co-Founder Nicholas Benedict also participated.
The proceeds will fund Phase 2 development of AAI202, Allecra's proprietary, novel antibiotic combination designed to treat drug-resistant Gram-negative bacterial infections. AAI202 is a combination of a powerful β-lactam antibiotic together with a proprietary, novel Extended Spectrum β-Lactamase Inhibitor. The combination is designed for use as
The Overseas Private Investment Corporation (OPIC), the US government’s development finance institution, has commenced the initial disbursement of a USD250 million loan to Apollo Towers Myanmar Limited, based in Yangon.
The disbursement marks OPIC’s first financing in the country as well as a historic milestone in public-private cooperation. Investors TPG Growth, Tillman Global Holdings, and Myanmar Investments International Limited facilitated the loan process and will continue to partner with Apollo on its expansion.
The development of towers by Apollo Towers Myanmar Limited (Apollo) has contributed to an increase in Myanmar’s mobile phone penetration rate from 5 percent to more
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
